These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12078125)

  • 1. [10 years' of production and use of human rabies immunoglobulin in Yugoslavia].
    Romić M; Tomović O; Medić P; Pelević S; Sindić M; Popović M; Gligorović V; Bogdanović G; Mitrović M; Petrović M; Stankov S; Lazarević-Ivanc L; Lalosević V; Lalosević D
    Med Pregl; 2001; 54 Suppl 1():33-7. PubMed ID: 12078125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rabies in dogs and efficacy of active immunoprophylaxis in Yugoslavia].
    Stankov S; Lalosević D; Pavlović R; Lalosević V; Knezević N; Budincević I
    Med Pregl; 1998; 51 Suppl 1():43-6. PubMed ID: 9769655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post exposure human-prophylaxis for rabies in developing countries.
    Onyemelukwe GC
    Afr J Med Med Sci; 1992 Dec; 21(2):1-12. PubMed ID: 1308073
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies.
    Prosniak M; Faber M; Hanlon CA; Rupprecht CE; Hooper DC; Dietzschold B
    J Infect Dis; 2003 Jul; 188(1):53-6. PubMed ID: 12825170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rabbit anti-rabies immunoglobulins production and evaluation.
    Liu X; Liu Q; Feng X; Tang Q; Wang Z; Li S; Feng Z; Zhu J; Guan X
    Trop Biomed; 2011 Apr; 28(1):138-48. PubMed ID: 21602780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of human rabies in Yugoslavia].
    Lalosević D; Lalosević V; Petrović R
    Med Pregl; 1998; 51 Suppl 1():25-30. PubMed ID: 9769652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity.
    Bakker AB; Python C; Kissling CJ; Pandya P; Marissen WE; Brink MF; Lagerwerf F; Worst S; van Corven E; Kostense S; Hartmann K; Weverling GJ; Uytdehaag F; Herzog C; Briggs DJ; Rupprecht CE; Grimaldi R; Goudsmit J
    Vaccine; 2008 Nov; 26(47):5922-7. PubMed ID: 18804136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eighty years of Pasteur Institute in Novi Sad and a century of scientific rabies prophylaxis in Serbia.
    Lalosević D
    Med Pregl; 2001; 54 Suppl 1():7-22. PubMed ID: 12078132
    [No Abstract]   [Full Text] [Related]  

  • 9. BHK-21 cell culture rabies vaccine: immunogenicity of a candidate vaccine for humans.
    Lalosević D; Lalosević V; Lazarević-Ivanc Lj; Knezević I
    Dev Biol (Basel); 2008; 131():421-9. PubMed ID: 18634504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical trial of YU BHK Rabivak vaccine against rabies in volunteers].
    Lalosević V; Lazarević-Ivanc L; Lalosević D
    Med Pregl; 2001; 54 Suppl 1():23-7. PubMed ID: 12078123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of passive rabies immunotherapy: from the past to the future].
    Bourhy H; Dacheux L; Ribadeau-Dumas F
    Biol Aujourdhui; 2010; 204(1):71-80. PubMed ID: 20950578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rabies and post-exposure rabies prophylaxis in Canada, 1987-1988.
    Varughese PV; Carter AO
    Can Dis Wkly Rep; 1990 Jul; 16(28):131-6. PubMed ID: 2397528
    [No Abstract]   [Full Text] [Related]  

  • 13. Intradermal DNA vaccination in ear pinnae is an efficient route to protect cats against rabies virus.
    Tesoro-Cruz E; Calderón-Rodríguez R; Hernández-González R; Blanco-Favéla F; Aguilar-Setién A
    Vet Res; 2008; 39(2):16. PubMed ID: 18215393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of tests for assessment of efficiency of vaccination for rabies prophylaxis. ].
    Nedosekov VV; Zhdanov NA; Kuril'chuk IuN
    Ter Arkh; 2004; 76(4):34-6. PubMed ID: 15174318
    [No Abstract]   [Full Text] [Related]  

  • 15. Fox rabies in India.
    Wilde H
    Clin Infect Dis; 2005 Feb; 40(4):614-5. PubMed ID: 15712087
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine.
    Deshpande AK; Londhe VA; Akarte S; Briggs D
    J Assoc Physicians India; 2003 Jul; 51():655-8. PubMed ID: 14621031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of terrestrial rabies in Western European countries.
    Cliquet F; Aubert M
    Dev Biol (Basel); 2004; 119():185-204. PubMed ID: 15747421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine.
    Malerczyk C; Briggs DJ; Dreesen DW; Banzhoff A
    J Travel Med; 2007; 14(1):63-4. PubMed ID: 17241256
    [No Abstract]   [Full Text] [Related]  

  • 19. [Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants].
    Koprowski H
    Arch Immunol Ther Exp (Warsz); 2002; 50(6):365-9. PubMed ID: 12549429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].
    Baysal B; Tosun S; Ozdemir M; Doğan M
    Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.